Trevor Hallam
2017 - SUTRO BIOPHARMA
In 2017, Trevor Hallam earned a total compensation of $677.9K as Chief Scientific Officer at SUTRO BIOPHARMA.
Compensation breakdown
| Non-Equity Incentive Plan | $134,000 |
|---|---|
| Salary | $393,975 |
| Other | $149,951 |
| Total | $677,926 |
Hallam received $394K in salary, accounting for 58% of the total pay in 2017.
Hallam also received $134K in non-equity incentive plan and $150K in other compensation.
Rankings
In 2017, Trevor Hallam's compensation ranked 10,743rd out of 14,666 executives tracked by ExecPay. In other words, Hallam earned more than 26.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,743 out of 14,666 | 27th |
Division Manufacturing | 4,186 out of 5,772 | 28th |
Major group Chemicals And Allied Products | 1,495 out of 2,075 | 28th |
Industry group Drugs | 1,223 out of 1,731 | 29th |
Industry Biological Products, Except Diagnostic Substances | 223 out of 313 | 29th |
Source: SEC filing on April 25, 2019.
Hallam's colleagues
We found two more compensation records of executives who worked with Trevor Hallam at SUTRO BIOPHARMA in 2017.
News
SUTRO BIOPHARMA CEO William Newell's 2021 pay jumps 161% to $5.6M
April 22, 2022
SUTRO BIOPHARMA CEO William Newell's 2020 pay falls 44% to $2.2M
April 29, 2021
SUTRO BIOPHARMA CEO William Newell's 2019 pay falls 56% to $3.8M
April 24, 2020
SUTRO BIOPHARMA CEO William Newell's 2018 pay jumps 1,136% to $8.7M
April 25, 2019